Jasper Therapeutics: Allergic Asthma Research Study Enrolling

Jasper Therapeutics:
Allergic Asthma Research Study Enrolling

Allergic Asthma
Research Study Enrolling
This clinical research study is now enrolling adults ages 18 to 65 who have mild/moderate allergic asthma. See if you may qualify!

Those who qualify may receive*:

• Compensation for travel
• Study-related care at no cost from local doctors/specialists
• Study medication at no cost

Take the next step to see if you may qualify for this study.
But don’t delay — space is limited!

Allergic Asthma
Research Study
Enrolling
This clinical research study is now
enrolling adults ages 18 to 65 who have mild/moderate allergic asthma.
See if you may qualify!

Those who qualify may receive*:

• Compensation for travel

• Study-related care at no cost from local doctors/specialists

• Study medication at no cost

Take the next step to see if you may qualify for this study. But don’t delay
— space is limited!

Why is this Jasper study on allergic asthma so important?

In Canada, over 3.8 million people have asthma1, and it’s believed that allergic asthma (or asthma triggered by allergens) is the most common form of this lung condition — even among adults. Yet a recent Asthma Canada survey found that 3 out of 4 of those with asthma reported having some form of health-related anxiety. This, they say, is because symptoms (like coughing, wheezing, excess mucus and difficulty breathing/shortness of breath) can force sufferers to limit their activities, which can lead to stress and isolation.

Forward

Why is this Jasper study on allergic asthma so important?

Asthma that’s triggered by allergies can be particularly troubling because allergens like pollen, dust mites, pet dander (and even some foods) are nearly impossible to avoid. Overall health may be further impacted due to poor sleep, having to stay indoors and/or being unable to exercise, which can result in higher rates of illness and hospitalization.

Back Forward

Why is this Jasper study on allergic asthma so important?

The purpose of this study is to assess an investigational medicine for allergic asthma. It has already been tested in healthy adults for safety. Now researchers want to see not only if it is safe, but if it can also help with lung function in adults with allergic asthma after being exposed to an allergen.

Researchers can do their part, but the development of new medicines is not possible without study volunteers. Know that even if you qualify and enroll, you can still withdraw from the study at any time, for any reason.

Act now to see if you may qualify.

Back Forward

How does it work?

Answer some questions
about your health

Tell us a little
bit about yourself

Connect to an available
study in your area

Just takes a few minutes

How does it work?

Answer some questions about your health

Tell us a little
bit about yourself

Connect to an available
study in your area

Just takes a few minutes

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.

Terms of Use / Privacy Policy

©2023 Acurian, Inc. All rights reserved.
* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.

1 https://www.canada.ca/en/public-health/services/publications/diseases-conditions/asthma-chronic-obstructive-pulmonary-disease-canada-2018.html. Asthma and Chronic Obstructive Pulmonary Disease (COPD) in Canada, 2018 – Canada.ca.